EHA Library - The official digital education library of European Hematology Association (EHA)

LOW-CYTOKINE ENVIRONMENT DETERMINES THE OUTCOME OF EMBRYONIC HEMATOPOIESIS IN MOUSE FETAL LIVER
Author(s): ,
Francisca Soares-Da-Silva
Affiliations:
Institut Pasteur,Paris,France
,
Márcia Peixoto
Affiliations:
Institut Pasteur,Paris,France
,
Laina Freyer
Affiliations:
Institut Pasteur,Paris,France
,
Rita Santos
Affiliations:
i3S,Porto,Portugal
,
Ramy Elsaid
Affiliations:
Institut Curie,Paris,France
,
Elisa Gomez-Perdiguero
Affiliations:
Institut Pasteur,Paris,France
,
Perpétua Pinto-do-Ó
Affiliations:
i3S,Porto,Portugal
Ana Cumano
Affiliations:
Institut Pasteur,Paris,France
EHA Library. Soares-Da-Silva F. 06/09/21; 324656; S248
Francisca Soares-Da-Silva
Francisca Soares-Da-Silva
Contributions
Abstract
Presentation during EHA2021: All Oral presentations will be made available as of Friday, June 11, 2021 (09:00 CEST) and will be accessible for on-demand viewing until August 15, 2021 on the Virtual Congress platform.

Abstract: S248

Type: Oral Presentation

Session title: Stem cell biology and microenvironment

Background

Hematopoietic stem cells (HSCs) are at the top of the hierarchy of the blood system. In the adult, they reside in the bone marrow, where they are mostly quiescent, only dividing to maintain the stem cell pool. During embryonic development, HSCs colonize the fetal liver where they expand. The fetal liver microenvironment is assumed to support HSC proliferation and is the only organ that provides the conditions for physiological HSC expansion. HSC transplantation is a widely used cell therapy in numerous disorders, including immunodeficiencies and leukemias. However, this therapy is still associated with high mortality rates, mainly due to infection, graft-versus-host disease (GvHD), and organ dysfunction, urging the need to improve the therapeutics. Robust and reproducible conditions to expand HSCs ex vivo would allow attaining sufficient numbers to reconstitute hematopoiesis in adult patients.

Aims

Understand the complexity of the HSC microenvironment in the fetal liver that promotes HSC expansion and differentiation into distinct lineages, to devise efficient strategies for HSC expansion ex vivo.

Methods

We characterized the stromal compartment of the fetal liver by spectral flow cytometry, and identified cytokine-producing cells by single-cell gene expression analysis. To localize the stromal cells in the tissue we used confocal microscopy in thin and thick sections, allowing a 3D reconstruction of the tissue microanatomy. For lineage tracing of yolk-sac erythromyeloid progenitors or HSCs, we used transgenic mice models.

Results

Characterization of fetal liver from E10-newborn revealed that the non-hematopoietic compartment represents only around 5% of total cells. Analysis of hepatoblasts, endothelial, perivascular, and mesothelial cells showed that all subsets express relevant but distinct patterns of hematopoietic cytokines. The chemoattractant Cxcl12, produced by perivascular cells, is the most expressed factor across liver development, while other cytokines such as Epo and Il7 are expressed at low-levels by hepatoblasts. In situ analysis showed that from the early stages of liver development, c-Kit+ hematopoietic cells are abundant close to the mesothelium and distinct hematopoietic lineages accumulate around blood vessels at E16.5. Lineage tracing experiments showed that, opposite to previous views, HSCs do not contribute to erythrocyte production up until birth, indicating that HSC differentiation in the embryo is skewed. We demonstrate that the low-levels of erythropoietin in the fetal liver confer a selective advantage of yolk sac-derived erythroid progenitors over HSC-derived progeny in the production of red blood cells.

Conclusion

Altogether, our work supports the premise that embryonic hematopoiesis is influenced by distinct niche cells that cooperate to provide the signals required for expansion and/or differentiation of hematopoietic stem and progenitor cells.

Keyword(s): Cytokine, Erythropoieisis, Hematopoietic stem and progenitor cells, Microenvironment

Presentation during EHA2021: All Oral presentations will be made available as of Friday, June 11, 2021 (09:00 CEST) and will be accessible for on-demand viewing until August 15, 2021 on the Virtual Congress platform.

Abstract: S248

Type: Oral Presentation

Session title: Stem cell biology and microenvironment

Background

Hematopoietic stem cells (HSCs) are at the top of the hierarchy of the blood system. In the adult, they reside in the bone marrow, where they are mostly quiescent, only dividing to maintain the stem cell pool. During embryonic development, HSCs colonize the fetal liver where they expand. The fetal liver microenvironment is assumed to support HSC proliferation and is the only organ that provides the conditions for physiological HSC expansion. HSC transplantation is a widely used cell therapy in numerous disorders, including immunodeficiencies and leukemias. However, this therapy is still associated with high mortality rates, mainly due to infection, graft-versus-host disease (GvHD), and organ dysfunction, urging the need to improve the therapeutics. Robust and reproducible conditions to expand HSCs ex vivo would allow attaining sufficient numbers to reconstitute hematopoiesis in adult patients.

Aims

Understand the complexity of the HSC microenvironment in the fetal liver that promotes HSC expansion and differentiation into distinct lineages, to devise efficient strategies for HSC expansion ex vivo.

Methods

We characterized the stromal compartment of the fetal liver by spectral flow cytometry, and identified cytokine-producing cells by single-cell gene expression analysis. To localize the stromal cells in the tissue we used confocal microscopy in thin and thick sections, allowing a 3D reconstruction of the tissue microanatomy. For lineage tracing of yolk-sac erythromyeloid progenitors or HSCs, we used transgenic mice models.

Results

Characterization of fetal liver from E10-newborn revealed that the non-hematopoietic compartment represents only around 5% of total cells. Analysis of hepatoblasts, endothelial, perivascular, and mesothelial cells showed that all subsets express relevant but distinct patterns of hematopoietic cytokines. The chemoattractant Cxcl12, produced by perivascular cells, is the most expressed factor across liver development, while other cytokines such as Epo and Il7 are expressed at low-levels by hepatoblasts. In situ analysis showed that from the early stages of liver development, c-Kit+ hematopoietic cells are abundant close to the mesothelium and distinct hematopoietic lineages accumulate around blood vessels at E16.5. Lineage tracing experiments showed that, opposite to previous views, HSCs do not contribute to erythrocyte production up until birth, indicating that HSC differentiation in the embryo is skewed. We demonstrate that the low-levels of erythropoietin in the fetal liver confer a selective advantage of yolk sac-derived erythroid progenitors over HSC-derived progeny in the production of red blood cells.

Conclusion

Altogether, our work supports the premise that embryonic hematopoiesis is influenced by distinct niche cells that cooperate to provide the signals required for expansion and/or differentiation of hematopoietic stem and progenitor cells.

Keyword(s): Cytokine, Erythropoieisis, Hematopoietic stem and progenitor cells, Microenvironment

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies